You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Albumin-Bound Paclitaxel

Showing 26 - 50 of 4,750
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Urothelial Carcinoma Trial in Beijing (anti-PD-L1 antibody, albumin bound paclitaxel)

Active, not recruiting
  • Advanced Urothelial Carcinoma
  • anti-PD-L1 antibody
  • albumin bound paclitaxel
  • Beijing, Beijing, China
    Beijing Tumor Hospital
Jan 20, 2022

Solid Tumor, Adult Trial (EOC202, albumin-bound paclitaxel)

Not yet recruiting
  • Solid Tumor, Adult
  • EOC202
  • albumin-bound paclitaxel
  • (no location specified)
Apr 7, 2022

To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast

Not yet recruiting
  • To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients
  • Monosialotetrahexose ganglioside sodium injection
  • (no location specified)
Mar 27, 2023

Cervical Cancer Trial in Beijing (HLX10+Albumin-Bound Paclitaxel)

Active, not recruiting
  • Cervical Cancer
  • HLX10+Albumin-Bound Paclitaxel
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
May 4, 2022

Recurrent Cervical Carcinoma, Persistent Advanced Cervical Carcinoma, Chemo Trial in Beijing (Anti-PD-1 antibody camrelizumab,

Recruiting
  • Recurrent Cervical Carcinoma
  • +5 more
  • Anti-PD-1 antibody camrelizumab
  • Albumin-bound paclitaxel
  • Beijing, Beijing, China
    Lei Li
Mar 12, 2022

Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced

Completed
  • Oral Cancer
  • PD-1 inhibitor+carboplatin+albumin-bound paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital
Nov 20, 2023

Soft Tissue Sarcoma Trial in Zhengzhou (Albumin-Bound Paclitaxel, Camrelizumab)

Recruiting
  • Soft Tissue Sarcoma
  • Zhengzhou, Henan, China
    Department of Bone and Soft Tissue, Henan Cancer Hospital
Jan 13, 2022

Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +5 more
  • Durvalumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shijiazhuang, Hebei, China
      Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
    Oct 25, 2023

    Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

    Not yet recruiting
    • Pancreatic Acinar Cell Carcinoma
    • +6 more
    • Nab paclitaxel
    • +5 more
    • (no location specified)
    Oct 30, 2023

    Gastric Cancer Trial in Wuhan (Albumin-bound Paclitaxel plus S-1, Oxaliplatin plus S-1)

    Recruiting
    • Gastric Cancer
    • Albumin-bound Paclitaxel plus S-1
    • Oxaliplatin plus S-1
    • Wuhan, Hubei, China
      Tongji hospital of Tongji Medical College, Huazhong University o
    Jan 3, 2022

    Head and Neck Squamous Cell Carcinoma Trial (Camrelizumab+Apatinib mesylate+Albumin-bound paclitaxel+cisplatin)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Camrelizumab+Apatinib mesylate+Albumin-bound paclitaxel+cisplatin
    • (no location specified)
    Dec 29, 2021

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast

    Not yet recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +4 more
    • BET Bromodomain Inhibitor ZEN-3694
    • +3 more
    • (no location specified)
    Jun 28, 2022

    Metastatic Pancreatic Ductal Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial

    Not yet recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • +3 more
    • Biopsy
    • +8 more
    • (no location specified)
    Jan 13, 2023

    Untreated Metastatic Pancreatic Ductal Adenocarcinoma Trial in Scottsdale (Nivolumab, Albumin-bound paclitaxel, Paricalcitol)

    Active, not recruiting
    • Untreated Metastatic Pancreatic Ductal Adenocarcinoma
    • Scottsdale, Arizona
      HonorHealth Research Institute
    Feb 15, 2022

    Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,

    Suspended
    • Distal Bile Duct Adenocarcinoma
    • +7 more
    • Duarte, California
      City of Hope Medical Center
    Dec 8, 2022

    Advanced Solid Tumor Trial in Shanghai (JS015, Toripalimab, Paclitaxel)

    Not yet recruiting
    • Advanced Solid Tumor
    • JS015
    • +10 more
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Nov 17, 2023

    Pancreatic Cancer Trial in Shanghai (IN10018, Albumin-Bound Paclitaxel, Gemcitabine)

    Recruiting
    • Pancreatic Cancer
    • Shanghai, Shanghai, China
      Renji Hospital of Shanghai Jiaotong University School of Medicin
    Apr 23, 2023

    Pancreatic Cancer Trial in Tianjin (albumin-bound paclitaxel)

    Recruiting
    • Pancreatic Cancer
    • albumin-bound paclitaxel
    • Tianjin, Tianjin, China
      Rui Liu
    Sep 14, 2021

    Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

    Recruiting
    • Breast Cancer
    • Hangzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Jun 28, 2022

    Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta

    Recruiting
    • Advanced Pancreatic Adenocarcinoma
    • +2 more
    • Atlanta, Georgia
    • +2 more
    Feb 28, 2022

    Advanced Breast Cancer Trial in Shijia Zhuang (SYHX2011, Paclitaxel for injection (albumin-bound))

    Not yet recruiting
    • Advanced Breast Cancer
    • SYHX2011
    • Paclitaxel for injection (albumin-bound)
    • Shijia Zhuang, Hebei, China
      The Fourth Hospital of Hebei Medical University
    Feb 22, 2023

    Head and Neck Squamous Cell Carcinoma, Neoadjuvant Treatment Trial in Zhuhai (Tislelizumab, Low-dose radiotherapy)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Neoadjuvant Treatment
    • Zhuhai, Guangdong, China
      Fifth Affilliated Hospital of Sun Yat-sen University
    Apr 22, 2022

    Recurrent Cervical Carcinoma, Persistent Advanced Cervical Carcinoma, Chemo Trial in Beijing (A combination of anti-PD-1

    Completed
    • Recurrent Cervical Carcinoma
    • +4 more
    • A combination of anti-PD-1 antibody camrelizumab and albumin-bound paclitaxel
    • Beijing, Beijing, China
      Lei Li
    Mar 12, 2022

    Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Trial in

    Completed
    • Borderline Resectable Pancreatic Adenocarcinoma
    • +6 more
    • Houston, Texas
    • +4 more
    Aug 31, 2022